Preclinical findings indicate that the peptide supports structural and functional preservation in a wide range of tissues, including the upper and lower gastrointestinal tract, hepatic and pancreatic tissue, skeletal muscle, ocular structures, cardiac tissue, and neural systems
Cagrilintide and retatrutide are two investigational peptide-based medicines currently being studied for the treatment of obesity and related metabolic conditions
The six groups included (i) control group, (ii) stress group, (iii) group with DSIP one hour before stress experiments, (iv) DSIP 24 hours before stress experiments, (v) DSIP one hour before the last stress experiment and (vi) DSIP 24 hours before the last stress experiment
Probst T, Pryss RC, Langguth B, et al